Jobs / United States / Astrazeneca Pharmaceuticals Lp
Regulatory CMC Director (Cell & Gene Therapy)
Astrazeneca Pharmaceuticals Lp · 🇺🇸 3 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles3 certified filings for “Regulatory Affairs Director” (Regulatory Affairs Managers) in MA: $241k–$257k, median $257k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Are you ready to steer global CMC strategy for cell and gene therapies that redefine what’s possible for patients? This role positions you at the center of breakthrough programs, where your regulatory leadership translates pioneering science into high-quality submissions and decisive health authority interactions that accelerate access for people who need it most. Based in Santa Monica, CA or Gaithersburg, MD, you will shape end-to-end CMC regulatory pathways across development stages, partnering closely with technical, clinical, and quality leaders. How will you apply your expertise to anticipate risk, set clear direction, and drive rapid, global approvals for a growing pipeline? Accountabilities: • Global CMC Strategy: Provide strategic guidance during all stages of product development and lead the development and implementation of global CMC regulatory strategies for cell and gene therapy programs, enabling efficient approvals and risk-mitigated plans. • Regulatory Intelligence and Risk Management: Interpret global regulations and guidance to identify risks and provide clear, actionable input to cross-functional product teams; deliver regulatory assessments for manufacturing changes and quality compliance and participate in technical risk assessments. • Dossier Leadership and Health Authority Engagement: Partner with stakeholders to deliver CMC components of IND, IMPD, BLA, Master Files, amendments, and annual reports; develop health authority briefing documents; represent CMC regulatory affairs on product teams and in agency interactions; ensure submission quality, clarity, and accuracy. • Lifecycle Management: Manage and maintain regulatory dossiers throughout the product lifecycle, ensuring timely updates and robust documentation strategies that support development, scale-up, and post-approval changes. • Standards and Ways of Working: Support the development and maintenance of regulatory templates, best practices, and procedures that raise quality, consistency, and speed of execution across programs. • People Leadership: Support hiring, lead workflow, and develop staff; build and guide high-functioning teams to deliver complex program milestones. • Continuous Improvement: Perform other duties as required, championing simplification and data-driven approaches that shorten development cycles and improve submission readiness. Essential Skills/Experience: • Demonstrated ability to develop/maintain strong working relationships with cross-functional teams, participate on and/or lead multi-functional teams, handle and prioritize multiple projects, and work independently. • Excellent communication and collaboration skills to work in a fast paced start up environment. • Proficient leadership skills to successfully lead complex programs. Able to effectively build and lead high-functioning teams. • Ability to deal with time demands, incomplete information or unexpected events. • Attention to detail required. • Outstanding organizational skills with the ability to multi-task and prioritize. • MA/MS degree in life sciences required; advanced degree preferred (PhD, PharmD). • Experience of 10+ years with BS/BA; 8+ years with MS/MA or MBA; 6+ years with PhD. • Prior experience in cell/gene therapy. • In depth knowledge of global CMC regulations and understanding of evolving challenges and health authority expectations for cell therapies. • Experience in IND, IMPD, BLA, MAA filings. Desirable Skills/Experience: • Direct experience leading health authority meetings and negotiating CMC strategies with multiple regions. • Expertise in CGT-specific comparability strategies, potency assays, and control strategy development. • Familiarity with eCTD publishing tools and document management systems. • Track record deliveri